NSB Pharmaconnect Private Limited
About NSB Pharmaconnect Private Limited
Data last updated:
NSB Pharmaconnect Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the research and development sector. It was incorporated on 16 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UR2013PTC000628. Its GSTIN is 05AAECN3174F1ZO (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Neelam Bahukhandi and Sushil Shambhuprasad Baukhandi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 601 Sixth Floor Eden Senior Living & Wellness, Khasra No. 39 & 40 Mauza Chak Bhagwantpur Dehradun, Uttarakhand, India – 248009.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.18 Lakh, a decline of 81% compared to the previous year. For the same year it recorded a net loss of ₹7.56 Lakh (net margin -181%) and EBITDA of -₹9.39 Lakh (EBITDA margin -224.8%). Revenue has declined at a compounded annual rate (CAGR) of 44% over three years and 31% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
NSB Pharmaconnect Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. 601 Sixth Floor Eden Senior Living & Wellness, Khasra No. 39 & 40 Mauza Chak Bhagwantpur Dehradun, Uttarakhand, India – 248009
- IndustryResearch & Development, Research & Development
To see the full contact details of NSB Pharmaconnect Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of NSB Pharmaconnect is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of NSB Pharmaconnect Private Limited, buy the company report.
Financials of NSB Pharmaconnect Private Limited
FY 2025 filings availableNSB Pharmaconnect Private Limited reported revenue of ₹4.18 Lakh (down 81% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 31% over five years, including a 81% fall in the latest year. EBITDA fell 329% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -224.8% | ||||
| Net Profit Margin | -181% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of NSB Pharmaconnect Private Limited, buy the company report.
Board of directors of NSB Pharmaconnect Private Limited
NSB Pharmaconnect has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelam Bahukhandi | Director | 16 Apr 2013 | 13 Years 6 Months | Current |
| Sushil Shambhuprasad Baukhandi | Director | 16 Apr 2013 | 13 Years 6 Months | Current |
Peer comparison
NSB Pharmaconnect Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ashtral Biotech Private Limited | ₹4.3 Lakh (FY 2020) | -62.0% | Chennai, Tamil Nadu, India | |||
| Cometa Tech Solutions Private Limited | ₹4.27 Lakh (FY 2025) | 112.0% | Ranchi, Jharkhand, India | |||
| Suryudey Plastic Electronics Private Limited | ₹4.26 Lakh (FY 2025) | -82.0% | Mumbai, Maharashtra, India | |||
| Ocare Healthtech Services Private Limited | ₹4.24 Lakh (FY 2022) | 119.0% | Mumbai, Maharashtra, India | |||
| Paleoclimate Ecology and Heritage Research Foundation | ₹4.21 Lakh (FY 2025) | Vadodara, Gujarat, India | ||||
| NSB Pharmaconnect Private Limitedthis company | ₹4.18 Lakh (FY 2025) | -₹7.56 Lakh | -181% | -81.0% | Dehradun, Uttarakhand, India | |
| Zygoscient Research Insights Private Limited | ₹4.14 Lakh (FY 2019) | Rourkela, Odisha, India | ||||
| Medscon Lifesciences Private Limited | ₹4.08 Lakh (FY 2020) | Mumbai, Maharashtra, India | ||||
| Structure Monitoring Technology Private Limited | ₹4.07 Lakh (FY 2024) | Nashik, Maharashtra, India | ||||
| Centella Scientific Private Limited | ₹4.06 Lakh (FY 2024) | 306.0% | Hyderabad, Telangana, India | |||
| Promotion of Science and Technology Foundation | ₹4.05 Lakh (FY 2025) | -67.0% | Noida Extension, Uttar Pradesh, India |
To see the full peer comparison of NSB Pharmaconnect Private Limited, buy the company report.
Auditor
NSB Pharmaconnect Private Limited is audited by SANJAY MISRA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY MISRA & CO. | FY 2017 | 520513 |
Shareholding
The shareholding of NSB Pharmaconnect Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of NSB Pharmaconnect Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving NSB Pharmaconnect Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for NSB Pharmaconnect Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
NSB Pharmaconnect has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECN3174F1ZO | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of NSB Pharmaconnect Private Limited, buy the company report.
Recent activity
NSB Pharmaconnect Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Neelam Bahukhandi was appointed as Director on 16 Apr 2013.
Frequently asked questions
NSB Pharmaconnect is an active private limited company based in Dehradun, Uttarakhand, India. The company works in the research and development industry. It was incorporated on 16 April 2013 (13+ years old) and is registered under CIN U74999UR2013PTC000628.
NSB Pharmaconnect has 2 current directors:
- Neelam Bahukhandi - Director
- Sushil Shambhuprasad Baukhandi - Director
The latest financial statements of NSB Pharmaconnect on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of NSB Pharmaconnect is 05AAECN3174F1ZO, registered in Uttarakhand.
The CIN (Corporate Identification Number) of NSB Pharmaconnect is U74999UR2013PTC000628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NSB Pharmaconnect was incorporated on 16 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of NSB Pharmaconnect by revenue are Ashtral Biotech Private Limited, Cometa Tech Solutions Private Limited, Suryudey Plastic Electronics Private Limited, Ocare Healthtech Services Private Limited, Paleoclimate Ecology and Heritage Research Foundation and 5 more, all in the same principal business activity (scientific research and development).
Neelam Bahukhandi was appointed as Director on 16 Apr 2013. Sushil Shambhuprasad Baukhandi was appointed as Director on 16 Apr 2013.
The registered office of NSB Pharmaconnect is at Flat No. 601 Sixth Floor Eden Senior Living & Wellness, Khasra No. 39 & 40 Mauza Chak Bhagwantpur Dehradun, Uttarakhand, India – 248009.
NSB Pharmaconnect operates in the research and development industry.
The compliance status of NSB Pharmaconnect is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.